Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06219408 · ClinicalTrials.gov registry record · NA

CIH Stepped Care for Co-occurring Chronic Pain and PTSD

A NA study of Chronic Pain and Post Traumatic Stress Disorder, sponsored by University of Washington.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06219408: Recruiting NA study of Chronic Pain and Post Traumatic Stress Disorder, sponsored by University of Washington.

NCT06219408 is a NA study of Chronic Pain and Post Traumatic Stress Disorder that is actively recruiting participants, run by University of Washington. The registered enrollment target is 60 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06219408, a NA study of Chronic Pain and Post Traumatic Stress Disorder, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to evaluate the feasibility, acceptability, appropriateness, and retention of patient participants of a CIH Stepped Care approach for co-occurring chronic pain and PTSD vs. treatment as usual in two primary care settings (one rural and one urban). Researchers will compare CIH Stepped Care to treatment as usual. Participants will complete assessments at baseline, 3-months, 6-months, and 9-months, and those in the CIH Stepped Care condition will participate in the intervention while also completed assessments every 2-weeks, which helps determine their treatment. We hypothesize that, at 6-months, CIH Stepped Care will be feasible, acceptable, and appropriate (defined by an average of 4/5 on each measure) to patients and clinic employees and result in at least 70% of individuals be retained in each condition (n=21 per condition).

Primary Outcome

Feasibility of intervention; 1-5; higher scores indicate greater feasibility

Interventions

  • BEHAVIORAL CIH Stepped Care

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2026-02-18
Est. Completion 2027-08-30
Phase NA
University of Washington

1,048 total trials

What NCT06219408 shows while recruiting

NCT06219408 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (92% lower).

The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which CIH Stepped Care is the first listed.

NCT06219408 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT06219408 about?

NCT06219408 is a clinical study titled "CIH Stepped Care for Co-occurring Chronic Pain and PTSD". The goal of this clinical trial is to evaluate the feasibility, acceptability, appropriateness, and retention of patient participants of a CIH Stepped Care approach for co-occurring chronic pain and PTSD vs. treatment as usual in two primary care settings (one rural and one urban). Researchers will...

What is the current status of trial NCT06219408?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-02-18. Estimated completion is 2027-08-30.

What conditions does trial NCT06219408 study?

This clinical trial studies the following conditions: Chronic Pain, Post Traumatic Stress Disorder.

What interventions are being tested in trial NCT06219408?

The interventions under investigation include: CIH Stepped Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT06219408?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06219408 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06219408's enrollment target sits among peer trials

60 176th of 301 higher than 112 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06219408, the US trial registry maintained by the National Library of Medicine. NCT06219408 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.